反应 #359

ord-ea53d8feb8094f94b89810756f770f19

反应方程式

Cc1cccc(C)c1C(=O)NC(c1ccc(Br)cc1)C12CCC(CC1)N2C
Cc1cccc(C)c1C(=O)NC(
C1COCCN1
C1COCCN1
Cc1cccc(C)c1C(=O)NC(c1ccc(N2CCOCC2)cc1)C12CCC(CC1)N2C
Cc1cccc(C)c1C(=O)NC(
收率 29.6%

溶剂

反应条件

温度
130°CELSIUS

实验过程

In a CEM microwave vial was N-((4-bromophenyl)(7-methyl-7-azabicyclo[2.2.1]heptan-1-yl)methyl)-2,6-dimethylbenzamide (100 mg, 0.23 mmol), morpholine (0.082 mL, 0.94 mmol), palladium(II) acetate (5.25 mg, 0.02 mmol), BINAP (14.57 mg, 0.02 mmol), and potassium tert-butoxide (52.5 mg, 0.47 mmol) solid and DMF (2 mL) was added. The vial was capped and placed into the microwave at 300 watts, 130 °C for 4 minutes. After reaction completion, the the mixture was concentrated and crude taken up in CH2Cl2 and washed with water and dried (Na2SO4). The material was purified on a 12 gram Isco silica cartridge and eluted with 0% to 5% MeOH 2M NH3/CH2Cl2 to give a light yellowish solid 2,6-dimethyl-N-((7-methyl-7-azabicyclo[2.2.1]heptan-1-yl)(4-morpholinophenyl)methyl)benzamide (30.0 mg, 29.6 %).

来源

750 AstraZeneca ELN dataset